Sale by Malievskaia Ekaterina of 11862 shares of Compass PathwaysPlc
| CMPS Stock | USD 4.75 0.30 6.74% |
Slightly above 55% of Compass Pathways' private investors are presently thinking to get in. The analysis of overall sentiment of trading Compass Pathways Plc stock suggests that some investors are interested at this time. Compass Pathways' investing sentiment can be driven by a variety of factors including economic data, Compass Pathways' earnings reports, geopolitical events, and overall market trends.
Compass |
Filed transaction by Compass Pathways Plc director. General open market or private sale of non-derivative or derivative security
Read at macroaxis.com
Compass Pathways Fundamental Analysis
We analyze Compass Pathways' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Compass Pathways using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Compass Pathways based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Owned By Institutions
Shares Owned By Institutions Comparative Analysis
Compass Pathways is currently under evaluation in shares owned by institutions category among its peers. Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
Compass Pathways Plc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Compass Pathways stock to make a market-neutral strategy. Peer analysis of Compass Pathways could also be used in its relative valuation, which is a method of valuing Compass Pathways by comparing valuation metrics with similar companies.
Peers
Compass Pathways Related Equities
| ACHC | Acadia Healthcare | 1.20 | ||||
| ADUS | Addus HomeCare | 0.89 | ||||
| AMED | Amedisys | 0.56 | ||||
| FSNUY | Fresenius | 0.46 | ||||
| USPH | US Physicalrapy | 0.39 | ||||
| CCRN | Cross Country | 0.11 | ||||
| DVA | DaVita HealthCare | 0.84 | ||||
| EHAB | Enhabit | 1.27 | ||||
| AGL | Agilon Health | 1.44 | ||||
| ENSG | Ensign | 1.84 | ||||
| SGRY | Surgery Partners | 2.61 | ||||
| NHC | National HealthCare | 3.27 | ||||
| PNTG | Pennant | 4.07 | ||||
| INNV | InnovAge Holding | 4.27 |
Additional Tools for Compass Stock Analysis
When running Compass Pathways' price analysis, check to measure Compass Pathways' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Compass Pathways is operating at the current time. Most of Compass Pathways' value examination focuses on studying past and present price action to predict the probability of Compass Pathways' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Compass Pathways' price. Additionally, you may evaluate how the addition of Compass Pathways to your portfolios can decrease your overall portfolio volatility.